Growth Metrics

Inmune Bio (INMB) Other Working Capital Changes (2018 - 2025)

Inmune Bio (INMB) has disclosed Other Working Capital Changes for 8 consecutive years, with -$624000.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 1850.0% to -$624000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43000.0 through Dec 2025, up 53.57% year-over-year, with the annual reading at $43000.0 for FY2025, 53.57% up from the prior year.
  • Other Working Capital Changes hit -$624000.0 in Q4 2025 for Inmune Bio, down from $673000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.7 million in Q4 2022 to a low of -$981000.0 in Q4 2021.
  • Historically, Other Working Capital Changes has averaged $97550.0 across 5 years, with a median of $12500.0 in 2022.
  • Biggest YoY gain for Other Working Capital Changes was 1432.43% in 2021; the steepest drop was 32800.0% in 2021.
  • Year by year, Other Working Capital Changes stood at -$981000.0 in 2021, then soared by 269.83% to $1.7 million in 2022, then tumbled by 99.88% to $2000.0 in 2023, then crashed by 1700.0% to -$32000.0 in 2024, then tumbled by 1850.0% to -$624000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for INMB at -$624000.0 in Q4 2025, $673000.0 in Q3 2025, and $31000.0 in Q2 2025.